Trial Profile
Safety and efficacy of dolutegravir + optimised background antiretroviral combinations in antiretroviral-experienced patients with HIV-2 infection within the French Named Patient Program
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Abacavir; Darunavir; Didanosine; Emtricitabine; Foscarnet; Lamivudine; Lopinavir; Maraviroc; Ritonavir; Saquinavir; Tenofovir disoproxil fumarate; Zidovudine
- Indications HIV-2 infections
- Focus Therapeutic Use
- 28 Nov 2015 New trial record